Biolife's agreement with Biogaia AB

20 June 2007

Colostrum is the milk that mammals produce during the first days after birth. This milk has a higher concentration of proteins and certain minerals and contains higher levels of anti-infection substances than mature milk.

Biolife has reached an agreement with Biogaia AB, Sweden. Biolife will sell BioGaia's portion packs, containing Lactobacillus reuteri and colostrum, in China. The product will be sold through food stores and pharmacies.

The product contains colostrum powder and BioGaia´s probiotic Reuteri culture. Colostrum is the milk that mammals produce during the first days after birth. This milk has a different composition than normal milk. In particular, it has a higher concentration of immune proteins and certain minerals and it also contains higher levels of anti-infection substances.
 

BioLife China, with Head Office in Guangzhou, sell colostrum products from New Zealand in 20 provinses in China. The company, with a yearly turnover of approximately 150 million kronor, introduced colostrum products in China in 1998 and have around 50 % of this market.The product will be manufactured at BioGaia´s fifty-percent owned company TwoPac AB in Eslöv and launch is expected during the second quarter of 2008. ”This is a new product in a difficult market but we believe that BioLife has great possibilites to succeed in China. With the new machinary we will have the opportunity to manufacture sachets with different ingredient mixes for other markets”, says Peter Rothschild, President, BioGaia AB.

ENDS
 

Back